These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36561021)

  • 1.
    Seniaray N; Verma R; Ranjan R; Belho E; Mahajan H
    Ann Indian Acad Neurol; 2022; 25(5):880-889. PubMed ID: 36561021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Functional Evaluation of the Spectrum of Multi-System Atrophy with
    Seniaray N; Verma R; Ranjan R; Belho E; Mahajan H
    Ann Indian Acad Neurol; 2021; 24(4):490-494. PubMed ID: 34728939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Amtage F; Hellwig S; Kreft A; Spehl T; Glauche V; Winkler C; Rijntjes M; Hellwig B; Weiller C; Weber WA; Tüscher O; Meyer PT
    Clin Nucl Med; 2014 Apr; 39(4):319-25. PubMed ID: 24566396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of
    Li L; Liu FT; Li M; Lu JY; Sun YM; Liang X; Bao W; Chen QS; Li XY; Zhou XY; Guan Y; Wu JJ; Yen TC; Jang MK; Luo JF; Wang J; Zuo C;
    Mov Disord; 2021 Oct; 36(10):2314-2323. PubMed ID: 34089275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy Body Dementia Associated with Anti-IgLON 5 Encephalitis Detected on
    Seniaray N; Verma R; Ranjan R; Belho E; Mahajan H
    Indian J Nucl Med; 2022; 37(1):94-96. PubMed ID: 35478670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
    Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
    Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
    Karbe H; Grond M; Huber M; Herholz K; Kessler J; Heiss WD
    J Neurol; 1992 Feb; 239(2):98-102. PubMed ID: 1552311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
    Zhao P; Zhang B; Gao S; Li X
    J Clin Neurosci; 2020 Oct; 80():318-323. PubMed ID: 32651138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy.
    Tomše P; Rebec E; Studen A; Perovnik M; Rus T; Ležaić L; Tang CC; Eidelberg D; Trošt M
    Phys Med; 2022 Jun; 98():131-138. PubMed ID: 35537328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
    Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
    Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
    Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
    Sood A; Shukla J; Shree R; Vatsa R; Modi M; Mittal BR
    Clin Nucl Med; 2021 Feb; 46(2):95-102. PubMed ID: 33234920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.
    Zalewski N; Botha H; Whitwell JL; Lowe V; Dickson DW; Josephs KA
    J Neurol; 2014 Apr; 261(4):710-6. PubMed ID: 24492888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction?
    Blin J; Horwitz B; Baron JC; Agid Y
    Eur J Neurol; 1995 Jan; 1(3):221-8. PubMed ID: 24283522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.